dabigatran has been researched along with Cholera Infantum in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyoshi, T; Hattori, T; Imaoka, A; Ohtani, H | 1 |
| Luna, JD; Manzano-Gamero, V; Pardo-Cabello, AJ | 1 |
| Cannegieter, SC; Huisman, MV; Klok, FA; Lijfering, WM; Rosendaal, FR; Teichert, M; Zielinski, GD | 1 |
| Briggs, N; De Silva, K; Dean, J; Dee, S; Jayathissa, S; Reid, S; Taylor, J; Thorne, K | 1 |
| Broncel, M; Ciastkowska, A; Duraj, I; Gorzelak-Pabiś, P; Szlagowska, L | 1 |
| Bonde, AN; Fosbøl, EL; Gislason, GH; Hansen, ML; Lamberts, M; Lip, GY; Olesen, JB; Staerk, L; Torp-Pedersen, C | 1 |
2 trial(s) available for dabigatran and Cholera Infantum
| Article | Year |
|---|---|
Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice.
Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Male; Medication Adherence; Middle Aged; Treatment Outcome | 2014 |
[Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Diseases; Hemorrhage; Humans; Male; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism | 2014 |
5 other study(ies) available for dabigatran and Cholera Infantum
| Article | Year |
|---|---|
Irinotecan-induced gastrointestinal damage impairs the absorption of dabigatran etexilate.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Dabigatran; Gastrointestinal Diseases; Intestinal Absorption; Intestinal Mucosa; Irinotecan; Male; Partial Thromboplastin Time; Rats | 2019 |
Comparative study of adverse drug reactions among direct-acting oral anticoagulants and vitamin K antagonists using the EudraVigilance database.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pharmacovigilance; Pyrazoles; Pyridones; Rivaroxaban; Vitamin K; Young Adult | 2021 |
Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Drug Prescriptions; Female; Gastrointestinal Diseases; Humans; Incidence; Male; Middle Aged; Netherlands; Proportional Hazards Models; Proton Pump Inhibitors; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke | 2018 |
Dabigatran: gastrointestinal ulcers.
Topics: Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Diseases; Humans; Ulcer | 2014 |
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Causality; Cohort Studies; Comorbidity; Dabigatran; Denmark; Female; Fibrinolytic Agents; Gastrointestinal Diseases; Humans; Incidence; Male; Risk Factors; Survival Rate; Thromboembolism; Treatment Outcome; Warfarin | 2015 |